Jul 26, 2023
Nexo Therapeutics launched with $60 million in Series A funding led by Versant Ventures and outlined a platform designed to discover covalent drugs against previously intractable…
Read moreJul 26, 2023
MD Anderson and Nexo Therapeutics announced a multi-year collaboration that combines Nexo's discovery platform with MD Anderson's TRACTION capabilities to move new small-molecule cancer therapies toward…
Read moreAug 4, 2023
BioWorld
Go to the original articleJul 27, 2023
MedCity News
Go to the original articleJul 27, 2023
Pharmaceutical Technology
Go to the original articleJul 27, 2023
C&EN
Go to the original articleJul 26, 2023
BioPharma Dive
Go to the original articleAug 4, 2023
BioWorld
Go to the original articleJul 27, 2023
MedCity News
Go to the original articleJul 27, 2023
Pharmaceutical Technology
Go to the original articleJul 27, 2023
C&EN
Go to the original articleJul 26, 2023
BioPharma Dive
Go to the original articleJul 26, 2023
Nexo Therapeutics launched with $60 million in Series A funding led by Versant Ventures and outlined a platform designed to discover covalent drugs against previously intractable…
Read moreJul 26, 2023
MD Anderson and Nexo Therapeutics announced a multi-year collaboration that combines Nexo's discovery platform with MD Anderson's TRACTION capabilities to move new small-molecule cancer therapies toward…
Read more